Xu et al., 2008 - Google Patents

Delivery of plasmid IGF‐1 to chondrocytes via cationized gelatin nanoparticles

Xu et al., 2008

Document ID
2766850980380935371
Author
Xu X
Capito R
Spector M
Publication year
Publication venue
Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials

External Links

Snippet

The objective of the present study was to investigate the use of gelatin and cationized‐ gelatin nanoparticles for the nonviral delivery of the plasmid DNA encoding for insulin‐like growth factor (IGF)‐1 to adult canine articular chondrocytes in vitro; plasmid for enhanced …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48776—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form forms of ingredients not provided for by groups A61K47/48784 - A61K47/48992, e.g. cells, cell fragments, viruses, ghosts, red blood cells, viral vectors having the pharmacologically or therapeutically active agent complexed or covalently linked to, or being themselves modified by complexation or covalent linkage by a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Xu et al. Delivery of plasmid IGF‐1 to chondrocytes via cationized gelatin nanoparticles
Elkhoury et al. Soft‐nanoparticle functionalization of natural hydrogels for tissue engineering applications
Ju et al. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration
He et al. Biomimetic hydrogels with spatial-and temporal-controlled chemical cues for tissue engineering
Jang et al. Gene delivery from polymer scaffolds for tissue engineering
Ji et al. Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications
Altomare et al. Biopolymer-based strategies in the design of smart medical devices and artificial organs
Dang et al. Natural polymers for gene delivery and tissue engineering
Bruggeman et al. Dynamic and responsive growth factor delivery from electrospun and hydrogel tissue engineering materials
Lei et al. Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery
Galperin et al. Integrated bi‐layered scaffold for osteochondral tissue engineering
Walsh et al. An efficient, non-viral dendritic vector for gene delivery in tissue engineering
Lorden et al. Integration of drug, protein, and gene delivery systems with regenerative medicine
Park et al. PLGA microsphere construct coated with TGF-β 3 loaded nanoparticles for neocartilage formation
US20130196915A1 (en) Affinity hydrogels for controlled protein release
Gonzalez‐Fernandez et al. Controlled Non‐Viral Gene Delivery in Cartilage and Bone Repair: Current Strategies and Future Directions
Wang et al. Design of gene-activated matrix for the repair of skin and cartilage
Jiang et al. Bone response to the multilayer BMP‐2 gene coated porous titanium implant surface
Poudel et al. Synthetic matrices for intestinal organoid culture: implications for better performance
Yue et al. BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector
Cao et al. Incorporating pTGF-beta1/calcium phosphate nanoparticles with fibronectin into 3-dimensional collagen/chitosan scaffolds: efficient, sustained gene delivery to stem cells for chondrogenic differentiation
Clegg et al. Vision for functionally decorated and molecularly imprinted polymers in regenerative engineering
Zhou et al. Self‐assembled biomimetic nano‐matrix for stem cell anchorage
Chen et al. Functionalizing titanium surface with PAMAM dendrimer and human BMP2 gene via layer‐by‐layer assembly for enhanced osteogenesis
Deepika et al. Applications of nanoscaffolds in tissue engineering